|
2024-12-06 |
2024-12-04 |
V
Vente
|
Mitchell Essex D
Chief Operating Officer
Dirigeant
|
24 856
-47.1%
76,34
1 897 482 USD
|
24 856
-47.1%
|
76,34
|
1 897 482 USD
|
|
|
2024-09-03 |
2024-08-29 |
VP
Vente planifiée
|
Oberton Karleen Marie
Chief Financial Officer
Dirigeant
|
52 679
-38.5%
80,56
4 243 662 USD
|
52 679
-38.5%
|
80,56
|
4 243 662 USD
|
|
|
2024-08-08 |
2024-08-06 |
V
Vente
|
Schnittker Brandon
Div. President, GYN Surgical
Dirigeant
|
476
-11.3%
83,11
39 559 USD
|
476
-11.3%
|
83,11
|
39 559 USD
|
|
|
2024-08-05 |
2024-08-01 |
VP
Vente planifiée
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
5 093
-32.7%
81,99
417 570 USD
|
5 093
-32.7%
|
81,99
|
417 570 USD
|
|
|
2024-08-01 |
2024-07-30 |
VP
Vente planifiée
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
20 228
-1.7%
82,32
1 665 169 USD
|
20 228
-1.7%
|
82,32
|
1 665 169 USD
|
|
|
2024-08-01 |
2024-07-30 |
VP
Vente planifiée
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
16 177
-1.4%
81,44
1 317 455 USD
|
16 177
-1.4%
|
81,44
|
1 317 455 USD
|
|
|
2024-08-01 |
2024-07-30 |
VP
Vente planifiée
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
7 634
-0.6%
80,60
615 300 USD
|
7 634
-0.6%
|
80,60
|
615 300 USD
|
|
|
2024-07-19 |
2024-07-17 |
VP
Vente planifiée
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
3 672
-0.3%
80,13
294 223 USD
|
3 672
-0.3%
|
80,13
|
294 223 USD
|
|
|
2024-07-19 |
2024-07-17 |
VP
Vente planifiée
|
Stamoulis Christiana
Administrateur non-exécutif
|
9 039
-16.6%
79,50
718 601 USD
|
9 039
-16.6%
|
79,50
|
718 601 USD
|
|
|
2024-03-15 |
2024-03-14 |
V
Vente
|
GARRETT SCOTT T
Administrateur non-exécutif
|
16 441
-25.3%
75,50
1 241 296 USD
|
16 441
-25.3%
|
75,50
|
1 241 296 USD
|
|
|
2024-03-11 |
2024-03-08 |
VP
Vente planifiée
|
Dockendorff Charles J
Administrateur non-exécutif
|
1 465
-48.2%
76,21
111 648 USD
|
1 465
-48.2%
|
76,21
|
111 648 USD
|
|
|
2024-03-11 |
2024-03-08 |
V
Vente
|
CRAWFORD SALLY
Administrateur non-exécutif
|
9 039
-6.4%
76,40
690 607 USD
|
9 039
-6.4%
|
76,40
|
690 607 USD
|
|
|
2024-01-30 |
2024-01-29 |
VP
Vente planifiée
|
Oberton Karleen Marie
Chief Financial Officer
Dirigeant
|
14 940
-12.6%
75,00
1 120 500 USD
|
14 940
-12.6%
|
75,00
|
1 120 500 USD
|
|
|
2024-01-04 |
2024-01-02 |
VP
Vente planifiée
|
Dockendorff Charles J
Administrateur non-exécutif
|
16 017
-91.6%
72,00
1 153 224 USD
|
16 017
-91.6%
|
72,00
|
1 153 224 USD
|
|
|
2023-12-13 |
2023-12-11 |
V
Vente
|
GARRETT SCOTT T
Administrateur non-exécutif
|
10 000
-17.5%
68,71
687 116 USD
|
10 000
-17.5%
|
68,71
|
687 116 USD
|
|
|
2023-12-01 |
2023-11-29 |
VP
Vente planifiée
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
47 711
-3.7%
70,41
3 359 188 USD
|
47 711
-3.7%
|
70,41
|
3 359 188 USD
|
|
|
2023-11-24 |
2023-11-21 |
V
Vente
|
Mitchell Essex D
Div. President, GYN Surgical
Dirigeant
|
7 500
-36.9%
71,85
538 890 USD
|
7 500
-36.9%
|
71,85
|
538 890 USD
|
|
|
2023-06-20 |
2023-06-15 |
V
Vente
|
GARRETT SCOTT T
Administrateur non-exécutif
|
10 000
-14.9%
79,72
797 240 USD
|
10 000
-14.9%
|
79,72
|
797 240 USD
|
|
|
2023-05-09 |
2023-05-05 |
VP
Vente planifiée
|
Mitchell Essex D
Div. President, GYN Surgical
Dirigeant
|
2 390
-24.9%
83,73
200 115 USD
|
2 390
-24.9%
|
83,73
|
200 115 USD
|
|
|
2023-02-09 |
2023-02-07 |
VP
Vente planifiée
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
9 128
-39.0%
85,28
778 445 USD
|
9 128
-39.0%
|
85,28
|
778 445 USD
|
|
|
2022-12-16 |
2022-12-14 |
V
Vente
|
Hellmann Elisabeth A
SVP, Human Resources
Dirigeant
|
1 649
-16.2%
76,40
125 984 USD
|
1 649
-16.2%
|
76,40
|
125 984 USD
|
|
|
2022-12-02 |
2022-11-30 |
V
Vente
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
12 501
-0.5%
76,02
950 326 USD
|
12 501
-0.5%
|
76,02
|
950 326 USD
|
|
|
2022-12-02 |
2022-11-30 |
V
Vente
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
20 999
-0.9%
75,43
1 584 039 USD
|
20 999
-0.9%
|
75,43
|
1 584 039 USD
|
|
|
2022-11-17 |
2022-11-15 |
V
Vente
|
Thornal Kevin R
Group Pres, Global Diagnostics
Dirigeant
|
12 490
-16.7%
75,30
940 509 USD
|
12 490
-16.7%
|
75,30
|
940 509 USD
|
|
|
2022-11-17 |
2022-11-15 |
V
Vente
|
Thornal Kevin R
Group Pres, Global Diagnostics
Dirigeant
|
6 628
-9.6%
75,37
499 552 USD
|
6 628
-9.6%
|
75,37
|
499 552 USD
|
|
|
2022-11-16 |
2022-11-14 |
V
Vente
|
Griffin John M.
General Counsel
Dirigeant
|
3 268
-1.9%
76,49
249 979 USD
|
3 268
-1.9%
|
76,49
|
249 979 USD
|
|
|
2022-11-16 |
2022-11-14 |
V
Vente
|
Griffin John M.
General Counsel
Dirigeant
|
23 634
-12.1%
76,07
1 797 909 USD
|
23 634
-12.1%
|
76,07
|
1 797 909 USD
|
|
|
2022-11-14 |
2022-11-11 |
V
Vente
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
42 893
-1.7%
75,94
3 257 294 USD
|
42 893
-1.7%
|
75,94
|
3 257 294 USD
|
|
|
2022-11-14 |
2022-11-11 |
V
Vente
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
52 529
-2.1%
75,57
3 969 564 USD
|
52 529
-2.1%
|
75,57
|
3 969 564 USD
|
|
|
2022-11-14 |
2022-11-11 |
V
Vente
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
43 000
-1.7%
75,64
3 252 520 USD
|
43 000
-1.7%
|
75,64
|
3 252 520 USD
|
|
|
2022-11-03 |
2022-11-01 |
VP
Vente planifiée
|
Oberton Karleen Marie
Chief Financial Officer
Dirigeant
|
14 545
-10.3%
72,50
1 054 513 USD
|
14 545
-10.3%
|
72,50
|
1 054 513 USD
|
|
|
2022-05-19 |
2022-05-17 |
V
Vente
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
3 844
-22.1%
78,75
302 730 USD
|
3 844
-22.1%
|
78,75
|
302 730 USD
|
|
|
2022-05-19 |
2022-05-17 |
V
Vente
|
Verstreken Jan
Group President, International
Dirigeant
|
6 500
-9.2%
78,80
512 168 USD
|
6 500
-9.2%
|
78,80
|
512 168 USD
|
|
|
2022-05-17 |
2022-05-13 |
V
Vente
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
3 842
-22.1%
75,49
290 033 USD
|
3 842
-22.1%
|
75,49
|
290 033 USD
|
|
|
2022-05-17 |
2022-05-13 |
V
Vente
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
3 210
-19.2%
75,49
242 333 USD
|
3 210
-19.2%
|
75,49
|
242 333 USD
|
|
|
2022-05-05 |
2022-05-03 |
VP
Vente planifiée
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
2 178
-13.9%
74,18
161 564 USD
|
2 178
-13.9%
|
74,18
|
161 564 USD
|
|
|
2022-02-28 |
2022-02-24 |
V
Vente
|
Daugherty Sean S.
Group President, BSH & Surg.
Dirigeant
|
2 179
-4.3%
71,14
155 016 USD
|
2 179
-4.3%
|
71,14
|
155 016 USD
|
|
|
2021-11-23 |
2021-11-19 |
V
Vente
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
2 570
-14.1%
75,79
194 791 USD
|
2 570
-14.1%
|
75,79
|
194 791 USD
|
|
|
2021-05-12 |
2021-05-10 |
V
Vente
|
Daugherty Sean S.
Group President, BSH & Surg.
Dirigeant
|
4 001
-13.1%
65,02
260 149 USD
|
4 001
-13.1%
|
65,02
|
260 149 USD
|
|
|
2021-02-09 |
2021-02-05 |
V
Vente
|
Bebo Allison P
SVP, Human Resources
Dirigeant
|
6 100
-14.6%
84,06
512 778 USD
|
6 100
-14.6%
|
84,06
|
512 778 USD
|
|
|
2021-02-08 |
2021-02-04 |
VP
Vente planifiée
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
8 396
-33.5%
84,31
707 867 USD
|
8 396
-33.5%
|
84,31
|
707 867 USD
|
|
|
2020-12-14 |
2020-12-10 |
V
Vente
|
Thornal Kevin R
Div. President, Diagnostics
Dirigeant
|
9 236
-21.8%
73,99
683 409 USD
|
9 236
-21.8%
|
73,99
|
683 409 USD
|
|
|
2020-12-14 |
2020-12-10 |
V
Vente
|
Thornal Kevin R
Div. President, Diagnostics
Dirigeant
|
7 633
-18.7%
74,00
564 804 USD
|
7 633
-18.7%
|
74,00
|
564 804 USD
|
|
|
2020-12-14 |
2020-12-10 |
V
Vente
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
1 477
-8.2%
73,64
108 759 USD
|
1 477
-8.2%
|
73,64
|
108 759 USD
|
|
|
2020-11-20 |
2020-11-18 |
V
Vente
|
Griffin John M.
General Counsel
Dirigeant
|
11 579
-7.9%
71,35
826 208 USD
|
11 579
-7.9%
|
71,35
|
826 208 USD
|
|
|
2020-11-20 |
2020-11-18 |
V
Vente
|
Griffin John M.
General Counsel
Dirigeant
|
11 321
-7.2%
70,80
801 482 USD
|
11 321
-7.2%
|
70,80
|
801 482 USD
|
|
|
2020-11-19 |
2020-11-17 |
V
Vente
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
5 000
-21.5%
72,58
362 900 USD
|
5 000
-21.5%
|
72,58
|
362 900 USD
|
|
|
2020-11-16 |
2020-11-12 |
V
Vente
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
6 542
-26.0%
70,60
461 846 USD
|
6 542
-26.0%
|
70,60
|
461 846 USD
|
|
|
2020-11-06 |
2020-11-04 |
VP
Vente planifiée
|
Stamoulis Christiana
Administrateur non-exécutif
|
11 146
-22.1%
74,00
824 804 USD
|
11 146
-22.1%
|
74,00
|
824 804 USD
|
|
|
2020-09-23 |
2020-09-21 |
VP
Vente planifiée
|
Oberton Karleen Marie
Chief Financial Officer
Dirigeant
|
15 000
-34.1%
62,50
937 500 USD
|
15 000
-34.1%
|
62,50
|
937 500 USD
|
|
|
2020-08-05 |
2020-08-03 |
VP
Vente planifiée
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
2 617
-13.5%
71,23
186 409 USD
|
2 617
-13.5%
|
71,23
|
186 409 USD
|
|
|
2020-08-05 |
2020-08-03 |
VP
Vente planifiée
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
369
-1.9%
71,22
26 280 USD
|
369
-1.9%
|
71,22
|
26 280 USD
|
|
|
2020-08-05 |
2020-08-03 |
VP
Vente planifiée
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
1 938
-10.4%
71,27
138 121 USD
|
1 938
-10.4%
|
71,27
|
138 121 USD
|
|
|
2020-07-02 |
2020-06-30 |
VP
Vente planifiée
|
Valenti Peter J. III
Division Pres., Breast Health
Dirigeant
|
10 493
-14.9%
54,07
567 357 USD
|
10 493
-14.9%
|
54,07
|
567 357 USD
|
|
|
2020-05-27 |
2020-05-22 |
V
Vente
|
Valenti Peter J. III
Division Pres., Breast Health
Dirigeant
|
10 493
-14.9%
51,82
543 779 USD
|
10 493
-14.9%
|
51,82
|
543 779 USD
|
|
|
2020-05-27 |
2020-05-22 |
V
Vente
|
CRAWFORD SALLY
Administrateur non-exécutif
|
31 950
-20.1%
51,99
1 661 081 USD
|
31 950
-20.1%
|
51,99
|
1 661 081 USD
|
|
|
2020-05-19 |
2020-05-15 |
V
Vente
|
Thornal Kevin R
Div. President, Diagnostics
Dirigeant
|
13 888
-44.9%
51,51
715 426 USD
|
13 888
-44.9%
|
51,51
|
715 426 USD
|
|
|
2020-05-15 |
2020-05-13 |
V
Vente
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
190 996
-10.0%
50,97
9 735 257 USD
|
190 996
-10.0%
|
50,97
|
9 735 257 USD
|
|
|
2020-04-30 |
2020-04-28 |
VP
Vente planifiée
|
Griffin John M.
General Counsel
Dirigeant
|
2 133
-2.2%
50,00
106 650 USD
|
2 133
-2.2%
|
50,00
|
106 650 USD
|
|
|
2020-04-30 |
2020-04-28 |
VP
Vente planifiée
|
Griffin John M.
General Counsel
Dirigeant
|
2 773
-2.8%
50,00
138 650 USD
|
2 773
-2.8%
|
50,00
|
138 650 USD
|
|
|
2020-03-11 |
2020-03-09 |
VP
Vente planifiée
|
CRAWFORD SALLY
Administrateur non-exécutif
|
7 846
-4.7%
44,29
347 523 USD
|
7 846
-4.7%
|
44,29
|
347 523 USD
|
|
|
2020-03-11 |
2020-03-09 |
VP
Vente planifiée
|
CRAWFORD SALLY
Administrateur non-exécutif
|
3 300
-1.9%
43,57
143 794 USD
|
3 300
-1.9%
|
43,57
|
143 794 USD
|
|
|
2020-02-05 |
2020-02-03 |
VP
Vente planifiée
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
194 396
-10.3%
53,54
10 407 184 USD
|
194 396
-10.3%
|
53,54
|
10 407 184 USD
|
|
|
2020-01-15 |
2020-01-13 |
VP
Vente planifiée
|
Griffin John M.
General Counsel
|
11 092
-10.4%
52,78
585 402 USD
|
11 092
-10.4%
|
52,78
|
585 402 USD
|
|
|
2020-01-15 |
2020-01-13 |
VP
Vente planifiée
|
Griffin John M.
General Counsel
|
8 532
-8.2%
52,97
451 932 USD
|
8 532
-8.2%
|
52,97
|
451 932 USD
|
|
|
2020-01-06 |
2020-01-02 |
VP
Vente planifiée
|
Oberton Karleen Marie
Chief Financial Officer
|
5 973
-17.1%
51,85
309 694 USD
|
5 973
-17.1%
|
51,85
|
309 694 USD
|
|
|
2020-01-06 |
2020-01-02 |
VP
Vente planifiée
|
Oberton Karleen Marie
Chief Financial Officer
|
10 375
-22.9%
51,66
535 993 USD
|
10 375
-22.9%
|
51,66
|
535 993 USD
|
|
|
2019-12-05 |
2019-12-04 |
V
Vente
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
4 379
-19.4%
52,12
228 225 USD
|
4 379
-19.4%
|
52,12
|
228 225 USD
|
|
|
2019-11-26 |
2019-11-22 |
V
Vente
|
COHN BENJAMIN JORDAN
Principal Accounting Officer
Dirigeant
|
4 400
-19.1%
50,09
220 400 USD
|
4 400
-19.1%
|
50,09
|
220 400 USD
|
|
|
2019-11-26 |
2019-11-22 |
V
Vente
|
Stamoulis Christiana
Administrateur non-exécutif
|
12 306
-24.9%
49,75
612 224 USD
|
12 306
-24.9%
|
49,75
|
612 224 USD
|
|
|
2019-11-13 |
2019-11-11 |
VP
Vente planifiée
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
126 956
-7.4%
46,16
5 859 908 USD
|
126 956
-7.4%
|
46,16
|
5 859 908 USD
|
|
|
2019-11-13 |
2019-11-11 |
VP
Vente planifiée
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
67 440
-3.8%
45,44
3 064 743 USD
|
67 440
-3.8%
|
45,44
|
3 064 743 USD
|
|
|
2019-09-05 |
2019-09-03 |
VP
Vente planifiée
|
Valenti Peter J. III
Division Pres., Breast Health
|
7 766
-13.4%
49,14
381 621 USD
|
7 766
-13.4%
|
49,14
|
381 621 USD
|
|
|
2019-08-07 |
2019-08-05 |
VP
Vente planifiée
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
81 945
-4.9%
49,26
4 036 938 USD
|
81 945
-4.9%
|
49,26
|
4 036 938 USD
|
|
|
2019-08-07 |
2019-08-05 |
VP
Vente planifiée
|
MACMILLAN STEPHEN P
Chairman, President and CEO
Administrateur exécutif
|
112 451
-6.3%
48,41
5 444 090 USD
|
112 451
-6.3%
|
48,41
|
5 444 090 USD
|
|
